FFT1P10: A Protein Witting Its Way To Cancer and Neurodegenerative Diseases
FFT1P10: A Protein Witting Its Way To Cancer and Neurodegenerative Diseases
FTH1P10, also known as FTHL10, is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the Fth domain family, which is known for its role in the development and maintenance of tight junctions, which are a type of cell-cell barrier that helps to maintain tissue structure and function.
FFT1P10 has been shown to play a role in a variety of physiological processes in the body, including the regulation of cell growth, differentiation, and survival. It has also been shown to be involved in the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
As a drug target, FFT1P10 is being studied for its potential to treat a wide range of conditions. For example, studies have shown that FFT1P10 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, FFT1P10 has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
In addition to its potential as a drug target, FFT1P10 has also been shown to be a valuable biomarker for a number of diseases. For example, studies have shown that FFT1P10 is highly expressed in the brains of individuals with Alzheimer's disease, and that it is involved in the development of neurofibrillary tangles and beta-amyloid plaques, which are hallmark features of this disease.
FFT1P10 is also being studied as a potential biomarker for other diseases, including cardiovascular disease, insulin resistance, and chronic obstructive pulmonary disease (COPD).
While more research is needed to fully understand the role of FFT1P10 in these diseases, studies have shown that it is an important player in many important biological processes. As such, FFT1P10 is a promising candidate for further research as a drug target and biomarker.
Protein Name: Ferritin Heavy Chain 1 Pseudogene 10
The "FTH1P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FTH1P10 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
FTH1P11 | FTH1P12 | FTH1P2 | FTH1P20 | FTH1P22 | FTH1P24 | FTH1P3 | FTH1P4 | FTH1P5 | FTH1P7 | FTH1P8 | FTHL17 | FTL | FTLP16 | FTLP2 | FTLP3 | FTLP7 | FTMT | FTO | FTO-IT1 | FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) | G Protein-Coupled Receptor Kinases (GRKs) | G0S2 | G2E3 | G2E3-AS1 | G3BP1 | G3BP2 | G6PC1 | G6PC2 | G6PC3 | G6PD | GA-binding protein | GAA | GAB1 | GAB2 | GAB3 | GAB4 | GABA(A) receptor | GABARAP | GABARAPL1 | GABARAPL2
